title: [Symptomatic sinus bradycardia induced by subcutaneous octreotide].
authors.forename: M
authors.initials: M
authors.lastname: Cruz Tejedor
authors.forename: Á L
authors.initials: ÁL
authors.lastname: Córdoba Sánchez
authors.forename: B
authors.initials: B
authors.lastname: Morató Bellido
authors.forename: Í
authors.initials: Í
authors.lastname: Martínez Gil
authors.forename: J E
authors.initials: JE
authors.lastname: Guerrero Sanz
mesh_terms: D000368:Aged; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced* / Q000188:drug therapy; D002037:Bundle-Branch Block / Q000150:complications; D002317:Cardiovascular Agents / Q000627:therapeutic use; D015897:Comorbidity; D004562:Electrocardiography; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging
chemical_list: D002317:Cardiovascular Agents; D001285:Atropine; D015282:Octreotide; D004837:Epinephrine